Literature DB >> 7785261

Molecular pathology and cancer genetic screening.

J P Gregg, W W Grody.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7785261      PMCID： PMC1022799     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  5 in total

1.  Cancer therapy meets p53.

Authors:  K W Kinzler; B Vogelstein
Journal:  N Engl J Med       Date:  1994-07-07       Impact factor: 91.245

2.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

3.  Presymptomatic diagnosis of familial adenomatous polyposis coli.

Authors:  J G Park; H J Han; M S Kang; Y Nakamura
Journal:  Dis Colon Rectum       Date:  1994-07       Impact factor: 4.585

4.  Direct, non-radioactive detection of mutations in multiple endocrine neoplasia type 2A families.

Authors:  R McMahon; L M Mulligan; C S Healey; S J Payne; M Ponder; M A Ferguson-Smith; D E Barton; B A Ponder
Journal:  Hum Mol Genet       Date:  1994-04       Impact factor: 6.150

Review 5.  Hereditary nonpolyposis colorectal carcinoma (HNPCC): clinical application of molecular diagnostic testing.

Authors:  P M Lynch
Journal:  Ann Med       Date:  1994-06       Impact factor: 4.709
  5 in total
  1 in total

1.  Expanding the utility of beta-galactosidase complementation: piece by piece.

Authors:  Ann-Marie Broome; Nihir Bhavsar; Gopalakrishnan Ramamurthy; Gail Newton; James P Basilion
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.